The board of directors declared a quarterly cash dividend of $1.73 per share. The payment is scheduled for August 14, 2026, to stockholders of record at the close of business on July 15, 2026. AbbVie Inc. operates in the pharmaceutical industry, researching and developing innovative medicines.
